文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

作者信息

Chakrapani Venkatesan, Velayudham Jaikumar, Shunmugam Murali, Newman Peter A, Dubrow Robert

机构信息

a Centre for Sexuality and Health Research and Policy (C-SHaRP) , Chennai , India.

出版信息

AIDS Care. 2014;26(7):835-41. doi: 10.1080/09540121.2013.861573. Epub 2013 Nov 28.


DOI:10.1080/09540121.2013.861573
PMID:24283220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4017592/
Abstract

India's National AIDS Control Organization provides free antiretroviral treatment (ART) to people living with HIV (PLHIV), including members of marginalized groups such as injecting drug users (IDUs). To help inform development of interventions to enhance ART access, we explored barriers to free ART access at government ART centers for IDUs living with HIV in Chennai by conducting three focus groups (n = 19 IDUs) and four key informant interviews. Data were explored using framework analysis to identify categories and derive themes. We found interrelated barriers at the family and social, health-care system, and individual levels. Family and social level barriers included lack of family support and fear of societal discrimination, as well as unmet basic needs, including food and shelter. Health-care system barriers included actual or perceived unfriendly hospital environment and procedures such as requiring proof of address and identity from PLHIV, including homeless IDUs; provider perception that IDUs will not adhere to ART, resulting in ART not being initiated; actual or perceived inadequate counseling services and lack of confidentiality; and lack of effective linkages between ART centers, needle/syringe programs, and drug dependence treatment centers. Individual-level barriers included active drug use, lack of self-efficacy in ART adherence, low motivation to initiate ART stemming from a fatalistic attitude, and inadequate knowledge about ART. These findings indicate that to facilitate IDUs gaining access to ART, systemic changes are needed, including steps to make the environment and procedures at government ART centers more IDU-friendly and steps to decrease HIV- and drug use-related stigma and discrimination faced by IDUs from the general public and health-care providers. Housing support for homeless IDUs and linkage of IDUs with drug dependence treatment are also essential.

摘要

相似文献

[1]
Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

AIDS Care. 2014

[2]
Barriers to free antiretroviral treatment access for female sex workers in Chennai, India.

AIDS Patient Care STDS. 2009-11

[3]
Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India.

AIDS Care. 2011-12

[4]
Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.

Int J Drug Policy. 2007-8

[5]
"They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.

PLoS One. 2018-8-30

[6]
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.

HIV Med. 2009-5-26

[7]
Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.

Subst Use Misuse. 2017-9-19

[8]
Scaling up HIV treatment, care and support for injecting drug users in Vietnam.

Int J Drug Policy. 2007-8

[9]
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.

J Epidemiol Community Health. 1999-1

[10]
Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.

AIDS Behav. 2019-4

引用本文的文献

[1]
The syndemic of incarceration, violence victimisation, needle/syringe sharing, & HIV infection: A population-based study of men who inject drugs in India.

Indian J Med Res. 2025-3

[2]
Mechanisms of resilience and coping to intersectional HIV prevention and drug-use stigma among people who inject drugs in rural Appalachian Ohio.

Harm Reduct J. 2025-2-19

[3]
Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.

JMIR Res Protoc. 2024-2-7

[4]
Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India.

Drug Alcohol Depend. 2023-8-1

[5]
Motivational Interviewing as an Intervention to Improve Antiretroviral Treatment Initiation Among People who Inject Drugs (PWID): A Pilot Study in Jakarta and Bandung, Indonesia.

Curr Drug Res Rev. 2024

[6]
HIV and its associated factors among people who inject drugs in Mizoram, Northeast India.

PLoS One. 2023

[7]
Changes in HIV care continuum indicators among community-based samples of HIV-infected people who inject drugs and men who have sex with men across 21 cities in India.

AIDS Care. 2023-10

[8]
Impact of the COVID-19 pandemic on HIV prevention and care services among key populations across 15 cities in India: a longitudinal assessment of clinic-based data.

J Int AIDS Soc. 2022-7

[9]
Diseases and Disparities: The Impact of COVID-19 Disruptions on Sexual and Reproductive Health Services Among the HIV Community in India.

Arch Sex Behav. 2022-1

[10]
A community approach to promote healthcare services for people living with HIV who use drugs in Vietnam.

Int J STD AIDS. 2022-2

本文引用的文献

[1]
Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning.

Bull World Health Organ. 2013-2-1

[2]
Scale-up of opioid substitution therapy in India: opportunities and challenges.

Int J Drug Policy. 2012-3

[3]
Barriers to free antiretroviral treatment access among kothi-identified men who have sex with men and aravanis (transgender women) in Chennai, India.

AIDS Care. 2011-12

[4]
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.

Lancet. 2010-7-31

[5]
The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India.

Drug Alcohol Depend. 2010-5-13

[6]
Barriers to free antiretroviral treatment access for female sex workers in Chennai, India.

AIDS Patient Care STDS. 2009-11

[7]
High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.

J Acquir Immune Defic Syndr. 2008-11-1

[8]
A review of barriers and facilitators of HIV treatment among injection drug users.

AIDS. 2008-7-11

[9]
Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.

Int J Drug Policy. 2007-8

[10]
Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union.

Int J Drug Policy. 2007-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索